Steve has 20 years of experience in the pharmaceutical industry, spanning market access consulting and commercial roles. He has worked directly with payers and providers to facilitate access to pharmaceutical products.
He has led numerous complex, strategic, global market access and HEOR projects for top 20 pharmaceutical clients and innovative biotech companies. His work includes advising on payer value strategy, clinical trial optimisation, evidence generation, and JCA/HTA and pricing strategy. Steve has consulted across the product lifecycle, from early pipeline to commercial launch and beyond, and regularly leads HTA/payer and KOL market research projects.
He has experience across multiple therapy areas, including oncology, rare diseases, haematology, neurology, immunology, cardiology, hepatology, gastroenterology, infectious diseases, and metabolic disorders. Steve holds an MBA from Durham University Business School.